Antibiotic resistance of Pseudomonas aeruginosa isolated from hospital wastewater in the Czech Republic
Author(s) -
Nikola Roulová,
Petra Moťková,
Iveta Brožková,
Marcela Pejchalová
Publication year - 2022
Publication title -
journal of water and health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.482
H-Index - 59
eISSN - 1996-7829
pISSN - 1477-8920
DOI - 10.2166/wh.2022.101
Subject(s) - ceftazidime , pseudomonas aeruginosa , antibiotic resistance , microbiology and biotechnology , piperacillin , amikacin , aztreonam , antibiotics , ciprofloxacin , tazobactam , meropenem , antimicrobial , biology , medicine , imipenem , bacteria , genetics
Resistant bacteria may leave the hospital environment through wastewater. The opportunistic pathogen Pseudomonas aeruginosa, due to its intrinsic resistance to many antibiotics and its ability to easily acquire antibiotic resistance determinants, poses a significant threat to public health. The aim of this study was to evaluate the antibiotic resistance profiles of cultivated P. aeruginosa in untreated hospital effluents in the Czech Republic. Fifty-nine P. aeruginosa strains isolated from six hospital wastewaters were tested for antimicrobial susceptibility through the disc diffusion method against seven antimicrobial agents. Resistance was found in all antibiotics tested. The highest resistance values were observed for ciprofloxacin (30.5%), gentamicin (28.8%), and meropenem (27.2%). The P. aeruginosa isolates also exhibited resistance to ceftazidime (11.5%), amikacin (11.5%), piperacillin-tazobactam (11.5%), and aztreonam (8.5%). Seventeen strains of P. aeruginosa (28.8%) were classified as multidrug-resistant (MDR). The results of this study revealed that antibiotic-resistant strains are commonly present in hospital wastewater and are resistant to clinically relevant antipseudomonal drugs. In the absence of an appropriate treatment process for hospital wastewater, resistant bacteria are released directly into public sewer networks, where they can serve as potential vectors for the spread of antibiotic resistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom